Since 2008, SMA Europe has had 10 calls for SMA research proposals. The Call is supported by a Scientific Advisory Board (SAB), which is composed of neuroscientists and neurologists with particular expertise in SMA research (please click here for a full list of members).
The SAB advise us on research grant applications and clinical trials initiatives aimed at finding a therapy for spinal muscular atrophy (SMA) or at elucidating the basic pathophysiological processes of the disease. Priority is however, given to projects concentrating on the following areas:
The overall goal of SMA-Europe is to help the dedicated international scientific and medical community in its search for therapies for SMA. Time being critical for people with SMA, preferences will be given to projects that have the greatest potential to overcome barriers to translation of advances in basic science and to accelerate the identification of effective treatments.
SMA Europe aims to launch its 11th Call for Research Proposals in 2022. This page will be updated in due course.